New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cytek Biosciences, Inc.
CTKB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

538M

Medical - Devices

Next Earning date - 14 May 2025

538M

Medical - Devices

Next Earning date - 14 May 2025

5.22USD

Shape0.02 ( 0.38%)
Market Closed (as of Feb 13, 23:07 EDT)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

4%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

32%

Quote Panel

Shape
Updated March 24, 2025
1W -0.94 % 1M -18.13 % 3M -35.68 % 1Y -34.27 %

Key Metrics

Shape
  • Market Cap

    538.01M


  • Shares Outstanding

    128.10M


  • Share in Float

    116.09M


  • Dividende

    0


  • Earning Date

    14 May 2025


  • Price Target

    4.2


  • Average Volume

    825043


  • Beta

    1.417


  • Range

    3.998-7.63


  • Industry

    Medical - Devices


  • Website

    https://cytekbio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CTKB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$207M

Shape514%

2025-Revenue

$0.01

Shape-87%

2025-EPS

$7M

Shape403%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

6.63(57.86%)

Number of analyst

2

Last analyst upgrade/downgrade

Stephens

initialise

Previous: Not converted

2023-12-14

Now: Positive

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.03
vs 0.01

Q2.23

arrow
arrow

-67%

0.01
vs 0.03

Q3.23

arrow
arrow

-75%

0.01
vs 0.04

Q4.23

arrow
arrow

N/A

0.07
vs 0.07

Q1.24

arrow
arrow

N/A

-0.05
vs -0.03

Q2.24

arrow
arrow

N/A

-0.08
vs 0.01

Q3.24

arrow
arrow

N/A

0.01
vs 0.01

Q4.24

arrow
arrow

N/A

0.07
vs 0.07

Q1.25

arrow
arrow

N/A

-0.03
vs -0.05

Q2.25

arrow
arrow

N/A

-0.02
vs -0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+6%

37.1M  vs 35.1M

Q2.23

arrow
arrow

+24%

49.7M  vs 40.2M

Q3.23

arrow
arrow

+19%

48M  vs 40.5M

Q4.23

arrow
arrow

+20%

58.2M  vs 48.3M

Q1.24

arrow
arrow

+21%

44.9M  vs 37.1M

Q2.24

arrow
arrow

-6%

46.6M  vs 49.7M

Q3.24

arrow
arrow

+7%

51.5M  vs 48M

Q4.24

arrow
arrow

-42%

33.7M  vs 58.2M

Q1.25

arrow
arrow

-3%

43.5M  vs 44.9M

Q2.25

arrow
arrow

+4%

48.4M  vs 46.6M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-2%

-0.02
vs 0.01

Q2.23

arrow
arrow

-1%

-0.01
vs -0.02

Q3.23

arrow
arrow

-2%

-0.02
vs -0.01

Q4.23

arrow
arrow

+1%

0.01
vs -0.02

Q1.24

arrow
arrow

-2%

-0.02
vs 0.01

Q2.24

arrow
arrow

-3%

-0.03
vs -0.02

Q3.24

arrow
arrow

+0%

0
vs -0.03

Q4.24

arrow
arrow

+2%

0.02
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

103

103
vs 105

-2%

Q2.23

arrow
arrow

104

104
vs 103

1%

Q3.23

arrow
arrow

108

108
vs 104

4%

Q4.23

arrow
arrow

102

102
vs 108

-6%

Q1.24

arrow
arrow

123

123
vs 102

21%

Q2.24

arrow
arrow

129

129
vs 123

5%

Q3.24

arrow
arrow

135

135
vs 129

5%

Q4.24

arrow
arrow

151

151
vs 135

12%

Earnings Growth

Latest News